Raymond James Financial Services Advisors
EBS icon

Raymond James Financial Services Advisors’s Emergent Biosolutions EBS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,953
Closed -$553K – 3325
2021
Q1 		$553K Sell
5,953
-1,909
-24% -$196K ﹤0.01% 2226
2020
Q4 		$704K Sell
7,862
-6,414
-45% -$589K ﹤0.01% 1934
2020
Q3 		$1.48M Buy
14,276
+10,412
+269% +$1.12M ﹤0.01% 1317
2020
Q2 		$306K Buy
+3,864
New +$288K ﹤0.01% 2218

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial Services Advisors's EBS Position: Q2 2021 in Review

Raymond James Financial Services Advisors sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 5,953 shares — an estimated $553K sold.

Raymond James Financial Services Advisors first reported a position in EBS in Q2 2020 and held it in 4 quarters. The position peaked at $1.48M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Raymond James Financial Services Advisors reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 5,953 Emergent Biosolutions shares in Q2 2021, an estimated $553K.
  • Raymond James Financial Services Advisors first reported a position in Emergent Biosolutions in Q2 2020 and held it in 4 quarters.
  • Raymond James Financial Services Advisors's Emergent Biosolutions position peaked at $1.48M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.